“HER2检测原则”经许可改编自“Wolff AC, Hammond MEH, Allison KH, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. ...
2022年12月美国国家综合癌症网络(National Comprehensive Cancer Network,NCCN)发布了2023年第1版《NCCN头颈部癌临床实践指南》(简称新版指南)[3],与2022年第2版指南(简称旧版指南)比较,主要在各类头颈部癌患者的手术治疗、放疗原则、系统性治疗原则及营...
2022.v4 NCCN临床实践指南:乳腺癌.pdf,® NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Breast Cancer Version 4.2022 — June 21, 2022 NCCN.org ® NCCN Guidelines for Patients available at /patients Continue ® ® ® Version 4.2
Lung cancer screening with LDCT is appropriate to consider for patients at high risk for cancer who are potential candidates for definitive treatment. Chest x-ray is not recommended for lung cancer screening. c Although age and smoking history are used for risk assessment, other potential risk fac...
Trends in Postmastectomy Therapy, Breast Reconstruction Linked to NCCN Guideline ChangesLourdes Briz
William J. Gradishar, MD, provides an overview of the current breast cancer treatment landscape, highlights updates to the NCCN guidelines from 2023 to 2024, and expresses optimism for addressing unmet needs at ASCO 2024. This is a modal window. The Playback API request failed for an ...
01.版本说明 2019年09月06号,NCCN Guideline_Breast Cancer进行了更新,更新后版本为Version 3.2019 02.Johnson阅读的目的: 虽然本人致力于开发肿瘤免疫治疗疗法,然而,肿瘤往往存在多种免疫耐受机制,想要逆转…
mbined-schedule.pdf, @& |. F/ j" {" B+ I ●疫苗作为一项预防感染的策略,对于癌症和移植后生存者代表一个独特的挑战。在活动性免疫功能低下的个体或残留免疫缺陷的生存者中,疫苗可能不能触发保护性免疫应答。此外,某些疫苗(如那些减毒活疫苗[如带状疱疹疫苗、麻疹-腮腺炎-风疹三联疫苗])禁用于活动性免疫...
Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5 Qiu Haibo et al., CMA Publishing House, 2018 An interpretation of the China edition of National Comprehensive Cancer Network(NCCN) clinical practice guideline for breast cancer 江泽飞 et al., CMA ...
Updates in CINV Including NCCN Guideline Revisions Sam Donaldson Hosts Roundtable on End-of-Life Care for Cancer Patients Clinical and Economic Considerations for the Use of Erythropoiesis-Stimulating Agents Challenges in Treating Chemotherapy-Induced Anemia Biology and Management of Diffuse Large B-cell...